Oculis Holding Correlations
OCSAW Stock | 4.25 0.04 0.93% |
The current 90-days correlation between Oculis Holding AG and Western Midstream Partners is 0.07 (i.e., Significant diversification). The correlation of Oculis Holding is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.
Oculis Holding Correlation With Market
Good diversification
The correlation between Oculis Holding AG and DJI is -0.16 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Oculis Holding AG and DJI in the same portfolio, assuming nothing else is changed.
Oculis |
Moving together with Oculis Stock
0.9 | DRUG | Bright Minds Biosciences Trending | PairCorr |
0.77 | SABSW | SAB Biotherapeutics | PairCorr |
0.79 | VRNA | Verona Pharma PLC | PairCorr |
0.72 | VSTM | Verastem Trending | PairCorr |
Moving against Oculis Stock
0.72 | ME | 23Andme Holding | PairCorr |
0.63 | DRMA | Dermata Therapeutics | PairCorr |
0.61 | DOMH | Dominari Holdings | PairCorr |
0.54 | A | Agilent Technologies | PairCorr |
0.51 | VALN | Valneva SE ADR | PairCorr |
0.39 | VCNX | Vaccinex | PairCorr |
0.8 | VINC | Vincerx Pharma | PairCorr |
0.67 | DTIL | Precision BioSciences Downward Rally | PairCorr |
0.61 | CDTTW | Conduit Pharmaceuticals | PairCorr |
0.6 | VRCA | Verrica Pharmaceuticals | PairCorr |
0.51 | VIRX | Viracta Therapeutics | PairCorr |
0.34 | VRAX | Virax Biolabs Group | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Risk-Adjusted Indicators
There is a big difference between Oculis Stock performing well and Oculis Holding Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Oculis Holding's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
WES | 1.14 | 0.08 | (0.01) | 0.42 | 1.35 | 2.48 | 5.82 | |||
PCYO | 1.72 | 0.33 | 0.22 | 0.33 | 1.42 | 4.75 | 13.79 | |||
CCU | 1.45 | (0.04) | (0.06) | 0.03 | 1.64 | 2.84 | 8.67 | |||
ATO | 0.68 | 0.17 | 0.13 | 0.54 | 0.49 | 1.85 | 3.85 | |||
WEC | 0.73 | 0.09 | 0.00 | 0.44 | 0.69 | 1.59 | 3.31 | |||
NI | 0.73 | 0.18 | 0.10 | 1.17 | 0.66 | 1.54 | 3.98 | |||
KNTK | 1.45 | 0.33 | 0.16 | 0.58 | 1.45 | 2.77 | 11.51 | |||
COCO | 1.61 | 0.47 | 0.21 | 1.14 | 1.50 | 3.72 | 11.39 |